secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0000950170-22-011675
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion Therapeutics stockholders elect directors and ratify auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Elected eight directors: Conrades, De Souza, Fanucci, Hecht, Isacson, Lovell, McGuire, Mendelsohn; each received over 22.4 million votes for.
- Ratified Ernst & Young as independent auditor for fiscal 2022 with 30,226,143 votes for, 53,476 against, 13,639 abstain.
- Broker non-votes totaled 7,253,724 on all director elections.
- Annual meeting held June 14, 2022; all proposals passed as recommended by the board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000095017022011675/0000950170-22-011675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000095017022011675/cycn-20220615.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer